Companies / Health Care / Pharmaceuticals
Lilly (Eli) stock buybacks
LLY$6.2Bbought back in the 12 months to Jun 30, 2026
Lilly (Eli) bought back $6.2B of its stock in the last twelve months, $5.5B more than it paid out in stock compensation. Its share count is down 0.7% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $0 |
| Q4 '20 | $0 |
| Q1 '21 | $0 |
| Q2 '21 | $500M |
| Q3 '21 | $0 |
| Q4 '21 | $750M |
| Q1 '22 | $1.5B |
| Q2 '22 | $0 |
| Q3 '22 | $0 |
| Q4 '22 | $0 |
| Q1 '23 | $750M |
| Q2 '23 | $0 |
| Q3 '23 | $0 |
| Q4 '23 | $0 |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $446.1M |
| Q4 '24 | $2.1B |
| Q1 '25 | $1.2B |
| Q2 '25 | $692M |
| Q3 '25 | $708.3M |
| Q4 '25 | $1.5B |
| Q1 '26 | $2.4B |
| Q2 '26 | $1.6B |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 911.4M |
| Q4 '20 | 916.0M |
| Q1 '21 | 912.4M |
| Q2 '21 | 910.4M |
| Q3 '21 | 910.8M |
| Q4 '21 | 913.1M |
| Q1 '22 | 906.4M |
| Q2 '22 | 902.9M |
| Q3 '22 | 903.8M |
| Q4 '22 | 905.4M |
| Q1 '23 | 903.3M |
| Q2 '23 | 902.7M |
| Q3 '23 | 899.8M |
| Q4 '23 | 907.4M |
| Q1 '24 | 903.8M |
| Q2 '24 | 904.2M |
| Q3 '24 | 905.0M |
| Q4 '24 | 903.4M |
| Q1 '25 | 900.6M |
| Q2 '25 | 899.8M |
| Q3 '25 | 898.8M |
| Q4 '25 | 898.0M |
| Q1 '26 | 895.9M |
| Q2 '26 | 893.7M |
$1.6Blast quarter (Q2 2026)
$5.5Bnet of stock compensation ($649M)
−0.7%diluted shares, 1 year
−1.4%diluted shares, 5 years
$5.8Bdividends, 12 months
—of free cash flow (—) spent on buybacks
$0raised by issuing stock, 12 months
$12.4Bleft under its authorization as of Sep 30, 2025
By fiscal year
Questions
- Does Lilly (Eli) buy back its stock?
- Lilly (Eli) bought back $6.2B of its stock in the last twelve months, $5.5B more than it paid out in stock compensation. Its share count is down 0.7% from a year earlier.
- How much did Lilly (Eli) spend on buybacks in fiscal 2025?
- $4.1B, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Lilly (Eli)'s share count going down?
- Its diluted share count changed −1.4% over five fiscal years and −0.7% over the last year.
- Does Lilly (Eli) have a buyback authorization?
- Its filings show $12.4B remaining under its repurchase authorization as of Sep 30, 2025.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 5, 2026 · open on SEC.gov